Remember our
EBPS 2021 5K walk-bike-skeeler-run »»
All times shown in the programme are
Right now, it is HH:mm (dd mmm 'YY) in Maastricht.
Visit also the EBPS Satellite Workshop programme »»
14:05-14:45
Welcome and Opening Remarks
Louk Vanderschuren (EBPS President)
Rudy Schreiber (Chair of the Local Organising Committee)
14:45-15:15
Opening Plenary Session
Lecture 1
Chair: Rudy Schreiber (Maastricht, The Netherlands)
David Nutt (London, United Kingdom)
Resurrecting psychedelic medicine through brain science
15:20-16:40
Parallel Sessions
Symposium 1: Neurocircuitry of traumatic stress and aversive learning; lessons learned from neuronal recordings to circuit manipulation
Chair: Rachel Moloney (Cork, Ireland)
Anna Beyeler (Bordeaux, France)
Role of divergent projection neurons of the insular cortex in anxiety- and valence-related behaviors
Thomas Kash (Chapel Hill, NC, USA)
Probing modulatory dynamics in the extended amygdala during aversive learning
Stephen Maren (College Station, TX, USA)
Neural circuits for stress-induced impairments in fear extinction
Rachel Moloney (Cork, Ireland)
Traumatic stress-induced changes in contextual fear learning; role of cortico-limbic circuitry
Symposium 2: New developments in alcohol use disorder research and drug development
Chair: Andrew Lawrence (Parkville, Australia)
Cody Siciliano (Nashville, TN, USA)
Kappa-opioid receptor regulation of reinforcement learning
Andrew Lawrence (Parkville, Australia)
Muscarinic acetylcholine receptors in alcohol use disorder
Estelle Barbier (Linköping, Sweden)
Synaptotagmin1 and alcohol-associated behaviors
Leigh Walker (Melbourne, Australia)
Sex differences in binge drinking: The role of cocaine and amphetamine regulated transcript (CART)
Symposium 3: The endocannabinoid system, neurodevelopment and autism
Chair: Michelle Roche (Galway, Ireland)
Michelle Roche (Galway, Ireland)
Endocannabinoid and opioid modulation of autistic-like behaviour in a the valproic acid model
Antonia Manduca (Rome, Italy)
Role of the endocannabinoid system in genetic and environmental preclinical models of ASD
Erica Zamberletti (Varese, Italy)
Cannabidivarin modulation of ASD-like signs in the prenatal valproic acid rat model of autism: behavioural and neurochemical studies
Eva Marco (Madrid, Spain)
The endocannabinoid system in the consequences of early life stress
16:45-18:05
Parallel Sessions
Symposium 4: Stress effects on neural coding of threat across timescales
Chair: Alfred Kaye (New Haven, CT, USA)
Wei-li Chang (New York, NY, USA)
Early life stress effects on fear-related ventral hippocampal activity
Alfred Kaye (New Haven, CT, USA)
Prefrontal acetylcholine and norepinephrine structure arousal after traumatic stress
Cornelius Gross (Rome, Italy)
Territory cells in the mammalian hypothalamus
Bianca Ambrogina Silva (Lausanne, Switzerland)
Brain circuits of fear attenuation
Symposium 5: Alternative strategies for drug addiction treatment
Chairs: Silvana De Pirro (Linköping, Sweden) & Marco Venniro (Baltimore, MD, USA)
Ingrid Reverte (Rome, Italy)
Effect of social choice-induced voluntary abstinence on incubation of methamphetamine craving and AMPA receptor expression in the nucleus accumbens core
Lilian Weber (Oxford, United Kingdom)
Towards fast, robust single-subject neural markers of decision making for computational psychiatry
Guru Løseth (Oslo, Norway)
Social support, stress relief and opioids: do the stress-relieving effects of social support depend on opioid-mediated mechanisms?
Margaret Haney (New York, NY, USA)
Human Laboratory Models of Drug Self-administration: Drug vs Money
Symposium 6: Neurobiological correlates and pharmacotherapeutic implications of the glucagon-like peptide-1 (GLP-1) system: An emerging target in neuropsychiatry
Chair: Mehdi Farokhnia (Baltimore, MD, USA)
Sriparna Ghosal (Lausanne, Switzerland)
The role of central glucagon-like peptide-1 (GLP-1) in stress regulation
Mehdi Farokhnia (Baltimore, MD, USA)
Glucagon-like peptide-1 (GLP-1) system is modulated by acute and chronic exposure to alcohol: findings from human laboratory experiments and a brain postmortem study
Rodrigo Mansur (Toronto, Canada)
Glucagon-like peptide-1 receptor (GLP-1R) agonists as potential treatments for cognitive dysfunction in mood disorders
Elizabeth Rhea (Seattle, WA, USA)
Blood-brain barrier transport of glucagon-like peptide-1 receptor (GLP-1R) agonists
18:05-18:10
Break
18:10-19:05
Poster Session 1
19:05-19:50
Plenary Session
Lecture 2
Chair: Louk Vanderschuren (Utrecht, The Netherlands)
Eveline Crone (Leiden, The Netherlands)
Adolescent brain development: A window of opportunity for social-affective engagement
20:00-20:45
Pubquiz
13:15-13:45
30 min Yoga
14:00-14:30
Plenary Session
Lecture 3
Chair: John Cryan (Cork, Ireland)
Joshua Buckholtz (Boston, MA, USA)
Cognitive and neurobiological mechanisms for self-control failure in psychiatric illness
14:35-15:55
Parallel Sessions
Symposium 7: Determining the role of habit in substance use disorders
Chair: Youna Vandaele (Prilly, Switzerland)
Christina Gremel (San Diego, CA, USA)
Alcohol dependence biasing habits? Loss of outcome devaluation and enhanced contingency control
Stephanie Groman (Minneapolis, MN, USA)
Model-free and model-based learning is disrupted following methamphetamine self-administration in rats
Youna Vandaele (Prilly, Switzerland)
Habitual preference for a nondrug reward in a drug choice setting
Lee Hogarth (Exeter, United Kingdom)
Habit and compulsion theories of addiction based on animal models have not translated successfully to humans
Symposium 8: Computational neuroethology
Chair: Sandeep Datta (Boston, MA, USA)
Jeffrey Markowitz (Boston, MA, USA)
Dopamine specifies the statistics of spontaneous behavior
Markus Marks (Zurich, Switzerland)
Deep-learning based identification, and end-to-end behavior classification for interacting primates and mice in complex environments
Christopher Harvey (Boston, MA, USA)
Machine learning pipelines for supervised behavior classification from raw video pixels
Ami Citri (Jerusalem, Israel)
Automated behavioral annotation unveils the role of the ventro-lateral striatum in cocaine-induced stereotypies
Symposium 9: Susceptibility to false memories following cannabis and MDMA: clinical and forensic implications
Chairs: Lilian Kloft (Maastricht, The Netherlands) & Jan Ramaekers (Maastricht, The Netherlands)
Lilian Kloft (Maastricht, The Netherlands)
Remembering Molly: immediate and delayed false memory formation after acute MDMA exposure
Manoj Doss (Baltimore, MD, USA)
Shared and unique effects of THC and MDMA on emotional memory, memory distortion, and subprocesses of episodic memory
Rachel Lees (Bath, United Kingdom)
Effect of 4-week cannabidiol treatment on memory and cognition in a clinical trial for cannabis use disorder
Sagnik Bhattacharyya (London, United Kingdom)
Associations between cannabis use, memory deficits and psychosis
15:55-16:10
15 min Yoga
16:10-17:30
Parallel Sessions
Symposium 10: The pharmacokinetic determinants of substance use disorder
Chair: Daniele Caprioli (Rome, Italy)
Daniele Caprioli (Rome, Italy)
The impact of continuously high versus intermittently high brain levels of heroin on incubation of craving
Susan Ferguson (Seattle, WA, USA)
Intermittent but not continuous access to illicit drugs produces individual variability in addiction susceptibility in rats
David Epstein (Baltimore, MD, USA)
The clinical relevance of temporal patterns of drug administration, onset of effects, and offset of effects
Florence Allain (Montreal, Canada)
Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior
Symposium 11: VTA glutamatergic neurons: often ignored but key players in the fields of innate behavior and psychopathology
Chairs: Marisela Morales (Baltimore, MD, USA) & Flavia Barbano (Baltimore, MD, USA)
William Wisden (London, United Kingdom)
The role of VTA glutamatergic neurons in sleep modulation
Flavia Barbano (Baltimore, MD, USA)
VTA glutamatergic neurons mediate innate defensive behavior
Ryan Drenan (Winston-Salem, NC, USA)
Nicotinic cholinergic modulation of VTA glutamate neurons
Matthew Anderson (Boston, MA, USA)
Sociability driving glutamate neurons in the ventral tegmental area: a convergent target of autism genetics and seizure effects
Symposium 12: An emerging role for neurofunctional domain approaches in modern CNS drug discovery
Chair: Rudy Schreiber (Maastricht, The Netherlands)
Sarah Morris with Bill Potter and Bruce Cuthbert (Bethesda, MD, USA)
A paradigm shift from DSM-5 to research domain criteria: application to translational CNS drug development
Laura Kwako with George Koob (Bethesda, MD, USA)
Application of neurofunctional domains in the development of novel therapeutics to treat SUD
Ulrike Schmidt (Bonn, Germany) with Eric Vermetten (Leiden, Netherlands)
Integration of research domain criteria into post-praumatic psychopathology
Jaymin Upadhyay (Boston, MA, USA) with Rudy Schreiber (Maastricht, Netherlands)
Evoked pain as a transdiagnostic tool for the characterization of neurofunctional domains in psychiatry: a focus on PTSD
17:35-18:05
Plenary Session
Lecture 4
Chair: Christelle Baunez (Marseille, France)
Marina Picciotto (New Haven, CT, USA)
Acetylcholine signaling in the basolateral amygdala during reward learning
18:05-18:10
Break
18:10-19:05
Poster Session 2
19:05-20:05
Introduction Alba network and fireplace chat with Carmen Sandi
12:30-13:00
30 min Yoga
13:15-13:45
Plenary Session
Young Scientist Award
Chair: Shelly Flagel (Ann Arbor, MI, USA)
Leah Mayo (Linköping, Sweden)
(Not) lost in translation: the endocannabinoid system as a novel target for stress-related disorders
13:45-14:30
Plenary Session
Distinguished Achievement Award
Chair: Louk Vanderschuren (Utrecht, The Netherlands)
Aldo Badiani (Rome, Italy)
Neuropharmacology of addictive drugs: Beyond pharmacodynamics and pharmacokinetics
14:35-15:55
Parallel Sessions
Symposium 13: Emotions in alcohol use and misuse – evidence from behavioural, eye tracking, and neuroimaging research
Chairs: Theodora Duka (Brighton, United Kingdom) & Aleksandra Herman (Warsaw, Poland)
Séverine Lannoy (Richmond, VA, USA)
Emotional disturbances in binge alcohol drinking
Aleksandra Herman (Warsaw, Poland)
Alexithymia and valence bias in alcohol binge drinking
Arthur Pabst (Louvain, Belgium)
Emotion recognition and beyond: toward an expansion of social cognition studies in severe alcohol use disorder (SAUD)
Kyriaki Nikolaou (Brighton, United Kingdom)
Emotional (dys)regulation in alcohol use disorder
Symposium 14: Propagating motivational value across the memory network
Chairs: Mihaela Iordanova (Montreal, Canada) & Nathan Holmes (Sydney, Australia)
Mihaela Iordanova (Montreal, Canada)
Differential dependence of secondary fear triggers on the original fear memory
Nathan Holmes (Sydney, Australia)
Connectivity between the perirhinal cortex and the basolateral amygdala regulate sensory preconditioning
Evan Hart (Baltimore, MD, USA)
Anterior cingulate neurons encode sensory associative information during sensory preconditioning
Arnau Busquets-Garcia (Barcelona, Spain)
Role of the hippocampus in sensory preconditioning
Symposium 15: Compulsivity and neurobehavioural plasticity
Chairs: Margarita Moreno (Almería, Spain) & Trevor Robbins (Cambridge, United Kingdom)
Tobias Hauser (London, United Kingdom)
Neural basis of compulsive behaviour in the developing adolescent human brain
Aude Belin-Rauscent (Cambridge, United Kingdom)
Neural system basis of compulsive cocaine-seeking in rats using MRI
Margarita Moreno (Almería, Spain)
Neurobehavioural basis of compulsive drinking in rats and its treatment
Martijn Figee (New York, NY, USA)
Treatment of OCD with deep brain stimulation
15:55-16:10
Break / Meet / Discuss
16:10-17:30
Parallel Sessions
Symposium 16: Corticostriatal mechanisms of inhibitory control: a tribute to Dawn Eagle
Chair: Amy Milton (Cambridge, United Kingdom)
Trevor Robbins (Cambridge, United Kingdom)
Fractionating impulsivity: neural and psychiatric implications
Christelle Baunez (Marseille, France)
The subthalamic nucleus in the circuit of inhibition control
Emma Robinson (Bristol, United Kingdom)
Investigating noradrenergic mechanisms and impulse control using translational animal models
Karly Turner (Sydney, Australia)
Are impulsive actions habitual?
Symposium 17: The role of the gut microbiome in drug addiction
Chairs: John Cryan (Cork, Ireland) & Rubén García-Cabrerizo (Cork, Ireland)
Rubén García-Cabrerizo (Cork, Ireland)
Microbiota-gut-brain axis as a regulator of reward and social processes: relevance to cocaine addiction
Nathalie Delzenne (Louvain, Belgium)
Gut microbiota on food and alcohol addiction
Drew Kiraly (New York, NY, USA)
Gut microbial metabolites play a critical role in opioid seeking and nucleus accumbens transcriptional control
Sabita Roy (Miami, FL, USA)
Gut microbiome brain axis in morphine tolerance
Symposium 18: Behavioral and molecular factors in cocaine reinforcement, choice, and reward
Chairs: William Stoops (Lexington, KY, USA) & Erin Calipari (Nashville, TN, USA)
Erin Calipari (Nashville, TN, USA)
Divergent molecular adaptations in the nucleus accumbens control cocaine reinforcement in males and females
Serge Ahmed (Bordeaux, France)
The history and significance of animal research on drug choice
William Stoops (Lexington, KY, USA)
Pharmacological manipulation of cocaine choice in humans
Karen Ersche (Cambridge, United Kingdom)
I know it is bad, but I’ll do it again
17:35-18:20
Nanopresentations
Chair: Heidi Lesscher (Utrecht, Netherlands)
Catarina Borges (Montreal, Canada)
Incubation of cue-induced heroin seeking after prolonged punishment-imposed abstinence and forced abstinence, in male rats
Lauri Elsilä (Helsinki, Finland)
LSD acutely reduces intermittent ethanol – but not sucrose – intake without observable effects on intracranial stimulation reward in C57BL/6 mice
Connor Haggarty (Linköping, Sweden)
Increased anandamide reduces affective evaluations of vicariously experienced affective touch in healthy humans
Rachel Jun (Baltimore, MD, USA)
Examination of neural ensembles encoding reward and punishment in mPFC - NAc projections
Sandra Ledesma Corvi (Palma de Mallorca, Spain)
Prodepressant- and neurogenic-like effects of electroconvulsive seizures in adult female rats
Igor Magaraggia (Maastricht, Netherlands)
Validation of natural language processing methods for the extraction of pharmacological data from subjective drug experiences available online
David Reiner (Baltimore, MD, USA)
Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats
Casper Wolf (Nijmegen, Netherlands)
Behavioral and cognitive effects of gamma-hydroxybutyric acid (GHB) and GHB-induced comas
James Collins (Cork, Ireland)
Gut microbiota depletion in early life reduces visceral sensitivity in adulthood
Olesya Shevchouk (Gothenburg, Sweden)
Divergent effects of GLP-1 analogues on sexual behaviour in experienced male mice
Débora Colodete (Ribeirão Preto, Brazil)
Evaluation of the behavioral effects induced by cannabidiol analogs
Tyler Dexter (London, Canada)
Assessing the role of prefrontal parvalbumin neurons in working memory – Combined pharmacology, optogenetics and touchscreen testing
Dillon McGovern (Boulder, CO, USA)
Ventral tegmental area glutamate neurons contribute to cue-induced oxycodone seeking behavior
Lars van der Velden (Utrecht, Netherlands)
The possible role of microbiota in the etiology of MDD
18:20-18:25
Break
18:25-19:20
Poster Session 3
13:00-14:00
EBPS General Assembly
14:00-15:20
Parallel Sessions
Symposium 19: Many faces of stress: different approaches to understand a complex phenomenon
Chair: Plinio Casarotto (Helsinki, Finland)
Carmen Sandi (Lausanne, Switzerland)
The power of behaviour to reveal vulnerability to stress-related disorders and underlying neural mechanisms
Sabine Spijker (Amsterdam, The Netherlands)
Incubation of depression
Caroline Biojone (Helsinki, Finland)
Modulation of TRKB by nitric oxide: from cellular mechanisms to behavior
Maurizio Popoli (Milan, Italy)
Stressed synapses, pathophysiology of mental illness and glutamate-based therapeutic approach
Symposium 20: Getting under the hood: Identifying the scope of dopamine’s role in learning (and behavior)
Chair: Geoffrey Schoenbaum (Baltimore, MD, USA)
Geoffrey Schoenbaum (Baltimore, MD, USA)
Identity prediction errors in the rat dopamine neurons and their role in stimulus-outcome learning
Thorsten Kahnt (Chicago, IL, USA)
Identity prediction errors in the human midbrain and their role in stimulus-outcome learning
Ingo Willuhn (Amsterdam, The Netherlands)
Regional specialization of dopamine transients in the rat striatum during appetitive and aversive stimulus-outcome learning
Roshan Cools (Nijmegen, The Netherlands)
Striatal dopamine-dependent effects of dopamine drugs on human stimulus-outcome learning
15:20-16:00
Break
16:05-17:25
Parallel Sessions
Symposium 21: The secret of the magic potion: Cognitive enhancement using pharmacology
Chair: Anke Sambeth (Maastricht, The Netherlands)
Carl Roberts (Liverpool, United Kingdom)
How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine
Anke Sambeth (Maastricht, The Netherlands)
Intellectual doping with cognition enhancing drugs
Dorothee Horstkötter (Maastricht, The Netherlands)
Cognitive Enhancement: the ethical debate
Symposium 22: Drug harms and drug policy
Chair: Jan Ramaekers (Maastricht, The Netherlands)
David Nutt (London, United Kingdom)
On ranking of drug harms
Wim van den Brink (Amsterdam, The Netherlands)
Developing a new national MDMA policy: Results of a multidecision multi-criterion decision analysis (MD-MCDA)
Jurgen Rehm (Toronto, Canada)
Changing policies on recreational and medical use of cannabis
Jan Ramaekers (Maastricht, The Netherlands)
Policy and research on novel psychoactive substances
Symposium 23: Do not lose it in the crowd. Novel statistical methods and machine learning techniques in assessing inter-individual variability in behavioral neuroscience
Chair: Kshitij Jadhav (Prilly, Switzerland)
Maxime Fouyssac (Cambridge, United Kingdom)
From heterogeneity to homogenous trends in individual trajectories: experimental and statistical approaches to study inter-individual differences in the vulnerability to addiction
Kshitij Jadhav (Prilly, Switzerland)
Combining supervised and unsupervised machine learning models to identify rats at higher risk of alcohol or cocaine use disorder
Brice Bathellier (Paris, France)
Capturing learning dynamics and interindividual variability in mice performing a sound discrimination task
Patricia Lockwood (Birmingham, United Kingdom)
A reinforcement learning approach to understanding prosocial behaviour
17:25-17:55
Closing Ceremony
P1.1 Incubation of cue-induced heroin seeking after prolonged punishment-imposed abstinence and forced abstinence, in male rats
Catarina Borges (Montreal, Canada)
P1.2 Investigating the effects of psilocybin on pre-pulse inhibition of the startle reflex and pattern separation in rats
Manon van den Berg (Maastricht, The Netherlands)
P1.3 LSD acutely reduces intermittent ethanol – but not sucrose – intake without observable effects on intracranial stimulation reward in C57BL/6 mice
Lauri Elsilä (Helsinki, Finland)
P1.4 A three-factor model of common early onset psychiatric disorders: temperament, adversity, and dopamine
Marco Leyton (Montreal, Canada)
P1.5 Characterizing acute post-operative use of opioid-analgesics in Norway
Isabell Meier (Oslo, Norway)
P1.6 Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats
David Reiner (Baltimore, MD, USA)
P1.7 Rodent alcohol self-administration in an operant home-cage setting: investigating the relationship between circadian drinking patterns and compulsive alcohol use
Madelief Zwaan (Amsterdam, The Netherlands)
P1.8 Role of ventral subiculum neuronal ensembles in incubation of oxycodone craving after electric barrier-induced voluntary abstinence
Ida Fredriksson (Baltimore, MD, USA)
P1.9 The effect of acute stressors on heroin seeking after punishment-imposed abstinence in rats
Jordan Charles (Montreal, Canada)
P1.10 Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms
Ellis Nelissen (Maastricht, The Netherlands)
P1.11 Mass spectrometry imaging visualizes region-specific neurotransmitter alterations of rat gambling strategies
Nikita Tjernström (Uppsala, Sweden)
P1.12 Prodepressant- and neurogenic-like effects of electroconvulsive seizures in adult female rats
Sandra Ledesma Corvi (Palma de Mallorca, Spain)
P1.13 Metabolomic alterations underlying compulsive behavior in a preclinical model
Santiago Mora (Canada de San Urbano, Spain)
P1.14 Extinction of Pavlovian conditioned approach: pharmacological and molecular underpinnings
Zuzana Vaverkova (Brighton, United Kingdom)
P1.15 Choice responding between social interaction and different doses of remifentanil in rats
Jonathan Chow (Baltimore, MD, USA)
P1.16 The potential of fluid and imaging biomarkers for the diagnosis of chronic traumatic encephalopathy (CTE)
Anna Bergauer (Maastricht, The Netherlands)
P1.17 Increased anandamide reduces affective evaluations of vicariously experienced affective touch in healthy humans
Connor Haggarty (Linköping, Sweden)
P1.18 Altered memory retrieval and frontal gene expression of HTR2A, Grin1, and BDNF in a preclinical model of compulsivity
Ángeles Prados-Pardo (Almería, Spain)
P1.19 Impaired decision-making and social regulation in a compulsive phenotype of rats selected by Schedule-Induced Polydipsia
Elena Martín-González (Almería, Spain)
P1.20 Early-life stress has persistent effects on reward-related behaviour
Ethan Dutcher (Cambridge, United Kingdom)
P1.21 Sex differences in the effect of chronic delivery of the mixed MOR/NOP agonists BU08028 and AT-201 on heroin relapse in a rat model of opioid maintenance
Lindsay Altidor (Baltimore, MD, USA)
P1.22 Medial septal neurons respond to punishment and cues predicting punishment
Jensine Coudriet (Baltimore, MD, USA)
P1.23 The role of negative affect in the addiction potential of undertreated pain patients
Sanda Kodele (Maastricht, The Netherlands)
P1.24 Validation of natural language processing methods for the extraction of pharmacological data from subjective drug experiences available online
Igor Magaraggia (Maastricht, The Netherlands)
P1.25 An examination of alcohol use and alcohol craving in AUD and non-AUD individuals during the COVID-19 pandemic
Bethany Stangl (Bethesda, MD, USA)
P1.26 Latent profiles of binge consumption during intravenous alcohol self-administration (IV-ASA) in humans
Vijay Ramchandani (Bethesda, MD, USA)
P1.27 The role of lateral hypothalamic GABAergic neurons in alcohol memories
Isis Alonso-Lozares (Amsterdam, The Netherlands)
P1.28 Behavioral and cognitive effects of gamma-hydroxybutyric acid (GHB) and GHB-induced comas
Casper Wolf (Nijmegen, The Netherlands)
P1.29 Examination of neural ensembles encoding reward and punishment in mPFC - NAc projections
Rachel Jun (Baltimore, MD, USA)
P2.1 Intermittent access heroin self-administration increases drug intake in both sexes and relapse vulnerability in female rats
Ginevra D'Ottavio (Rome, Italy)
P2.2 Into individual differences in social play behaviour in rats: behavioural microstructure and communication
Marijke Achterberg (Utrecht, The Netherlands)
P2.3 The effect of high-fat diet on impulsivity: lessons from a preclinical model
Diego Ruiz (Almería, Spain)
P2.4 Enduring effects on negative affect by adolescent cocaine exposure in female early-life stressed rats
Carles Colom-Rocha (Palma, Spain)
P2.5 Divergent effects of GLP-1 analogues on sexual behaviour in experienced male mice
Olesya Shevchouk (Gothenburg, Sweden)
P2.6 Central and peripheral effects of anthocyanin-rich tart cherries in a diet-induced obese model
Emanuela Micioni Di Bonaventura (Camerino, Italy)
P2.7 Blockade of sigma1 receptor as a promising pharmacological strategy for compulsive-like eating behaviour
Luca Botticelli (Camerino, Italy)
P2.8 Naltrexone attenuates the antidepressant-like effects of ketamine in differential-reinforcement-of-low-rate (DRL) 72 sec operant behavior in mice
Joseph Porter (Richmond, VA, USA)
P2.9 Resistant emotional memory and blunted HPA axis response stress in a compulsive phenotype of rats
Manuela Olmedo (Córdoba, Spain)
P2.10 Social reward versus alcohol, validation of an operant social choice model
Rie Matsuzaki (Amsterdam, The Netherlands)
P2.11 Experimental study of the effects of pre-gestational stress and/or treatment with antidepressant mirtazapine during gestation and lactation on offspring development
Mireia Viñas (Bratislava, Slovakia)
P2.12 Gut microbiota depletion in early life reduces visceral sensitivity in adulthood
James Collins (Cork, Ireland)
P2.13 The effects of adolescent intermittent alcohol exposure and social isolation on voluntary adult alcohol intake in rats
Cassie Chandler (Lexington, KY, USA)
P2.14 The role of the nucleus accumbens shell in alcohol use despite negative consequences in rats
Allison McDonald (Amsterdam, The Netherlands)
P2.15 Microglia depletion and activation are associated with cocaine-induced behavioral sensitization and changes in CX3CL1 and BDNF levels
Maria Carolina da Silva (Belo Horizonte, Brazil)
P2.16 Machine learning reveals the effects of sex and environment on the latent constituent motifs of aggression, social stress responses, and coping strategy selection
Nastacia Goodwin (Seattle, WA, USA)
P2.17 Inhibition of the canonical NFkB cascade reduces morbidity in a rat model of stroke but does not prevent the onset of behavioral disorders
Giacomo Einaudi (Camerino, Italy)
P2.18 Establishing a model of nicotine vapor self-administration in mice
John Gibbons (Baltimore, MD, USA)
P2.19 Short-term effects of early life stress on brain cytokine levels and mitochondrial dynamics of male and female rats
Eva Marco (Madrid, Spain)
P2.20 Chronic nighttime light exposure during adolescence induces neurotransmitter plasticity in the medial amygdala affecting anxiety-like behaviors in mice
Alessandra Porcu (La Jolla, USA)
P3.1 Evaluation of the behavioral effects induced by cannabidiol analogs
Débora Colodete (Ribeirão Preto, Brazil)
P3.2 Ventral tegmental area glutamate neurons contribute to cue-induced oxycodone seeking behavior
Dillon McGovern (Boulder, CO, USA)
P3.3 Who's laughing? Play, tickling and ultrasonic rats
Candace Burke (Lethbridge, Canada)
P3.4 Levetiracetam attenuates long-term behavioral changes and ventral tegmental area dopamine system dysregulation induced by adolescent stress
Andreza Cavichioli (Ribeirão Preto, Brazil)
P3.5 Don’t stress playtime! On the interaction of social play and glucocorticoids.
Tara Pimentel (Utrecht, The Netherlands)
P3.6 MicroRNA-34a Regulates the serotonin stress response through GABAergic transmission
Serafina Manila Guzzo (Camerino, Italy)
P3.7 Early-life experiences induce long-lasting physiological alteration of VTA dopaminergic neurons
Camilla Mancini (Camerino, Italy)
P3.8 Peer presence, like optogenetic modulation of the subthalamic nucleus, reverses escalated cocaine intake in rats
Cassandre Vielle (Marseille, France)
P3.9 Cocaine-seeking behaviour is differentially expressed in male and female mice exposed to maternal separation and is associated with alterations in AMPA receptors subunits in the medial prefrontal cortex
Adriana Castro-Zavala (Barcelona, Spain)
P3.10 The role of medial prefrontal cortex projections to the nucleus accumbens in rats experiencing motivational conflict
Amber van Mierlo (Amsterdam, The Netherlands)
P3.11 Brain-wide reconstruction of the neuronal ensembles engaged by incubation of highly palatable food craving and relapse in mice
Eric Szelenyi (Seattle, WA, USA)
P3.12 Modulation of RMTg GABA neurons on defensive threat responses under opioid-induced states
Annie Ly (Boulder, CO, USA)
P3.13 The possible role of microbiota in the etiology of MDD
Lars van der Velden (Utrecht, The Netherlands)
P3.14 Alcohol cue-induced craving linked to higher trait frustration and impulsivity
Julia Cebrián Abad (Madrid, Spain)
P3.15 Can computational techniques be utilized for the design of novel, selective serotonin 2A receptor ligands with a potential use for parkinson's disease induced psychosis?
Aedan O'Shea (Maastricht, The Netherlands)
P3.16 Assessing the role of prefrontal parvalbumin neurons in working memory – Combined pharmacology, optogenetics and touchscreen testing
Tyler Dexter (London, Canada)
P3.17 Molecular characterization of cocaine-relapse ensemble neurons in the infralimbic cortex using single nuclei RNA sequencing in Fos-mRFP transgenic rats
Ryan Palaganas (Baltimore, MD, USA)
P3.18 In vivo labeling and molecular characterization of active neurons in the infralimbic cortex using a photo-activatable calcium integrator (CaMPARI2)
Olivia Drake (Baltimore, MD, USA)
P3.19 Involvement of the subthalamic nucleus in electrical and optogenetic intracranial self-stimulation behavior
Maya Williams (Marseille, France)
P3.20 Altered cognition associated with persistent reduction of synaptic inhibition in the prefrontal cortex after social play deprivation in juvenile rats
Ate Bijlsma (Utrecht, The Netherlands)